Peripheral neuropathy secondary to cis-Dichlorodiammino-platinum (II) (Platinol) . Treatment for advanced ovarian cancer
Marin, A.C.; Rierson, B.
Arizona Medicine 36(12): 898-899
1979
ISSN/ISBN: 0004-1556 PMID: 229809 Document Number: 149127
Document emailed within 1 workday
Related Documents
Mandic, A.; Vujkov, T.; Malbasa, Z. 2003: Paclitaxel or docetaxel combined with platinum in advanced ovarian cancer? Journal of BUON: Official Journal of the Balkan Union of Oncology 8(1): 19-22Wachters, F.M.; Van Der Graaf, W.T.A.; Groen, H.J.M. 2004: Cardiotoxicity in advanced non-small cell lung cancer patients treated with platinum and non-platinum based combinations as first-line treatment Anticancer Research 24(3b): 2079-2083
Welch, R.S.; James, R.D.; Wilkinson, P.M.; Belli, F.; Cowan, R.A. 1995: Recombinant human erythropoietin and platinum-based chemotherapy in advanced ovarian cancer Cancer Journal from Scientific American 1(4): 261-266
Vogl, S.E.; Pagano, M.; Kaplan, B.H.; Einhorn, N.; Arseneau, J.; Moukhtar, M.; Greenwald, E. 1980: Combination chemotherapy of advanced ovarian cancer with hexamethylmelamine, cis-Platinum, and doxorubicin after failure of prior therapy Obstetrics and Gynecology 56(5): 635-640
Linasmita, V.; Wilailak, S.; Srisupundit, S.; Tangtrakul, S.; Bullangpoti, S.; Israngura, N. 1998: Epithelial ovarian cancer treated by platinum or platinum analogue with cyclophosphamide: experience in Ramathibodi Hospital Journal of the Medical Association of Thailand 81(1): 10-16
Bunn, P.A. 1999: Triplet chemotherapy with gemcitabine, a platinum, and a third agent in the treatment of advanced non-small cell lung cancer Seminars in Oncology 26(1 Suppl 4: 25-30
Panici, P.B.; Scambia, G.; Baiocchi, G.; Laurelli, G.; Greggi, S.; Battaglia, F.; Ragusa, G.; Salerno, G.; Gallo, A.; Cento, R. 1990: Rationale for very high-dose chemotherapy with peripheral blood stem cell support in advanced ovarian cancer Haematologica 75(Suppl 1): 87-89
Scotto, V.; Sbiroli, C. 1991: Weekly cis-platinum as third line chemotherapy in advanced ovarian carcinoma. Phase Ii study European Journal of Gynaecological Oncology 12(1): 51-53
Honma, H. 2006: Successful treatment of an elderly patient with advanced gastric cancer using low-doses of 5-fluorouracil, levofolinate calcium, and cis-platinum with chronomodulation Gan to Kagaku Ryoho. Cancer and ChemoTherapy 33(11): 1633-1636
Mayerhofer, K.; Bodner-Adler, B.; Bodner, K.; Leodolter, S.; Kainz, C. 2000: Paclitaxel/carboplatin as first-line chemotherapy in advanced ovarian cancer: efficacy and adverse effects with special consideration of peripheral neurotoxicity Anticancer Research 20(5c): 4047-4050
Donato, M.L.; Champlin, R.E.; Wharton, J.T.; Bodurka-Bevers, D.; Gershenson, D. 2000: Intensive-dose ifosfamide and etoposide with filgrastim for cytoreduction before peripheral blood stem cell collection in patients with advanced ovarian cancer European Journal of Gynaecological Oncology 21(3): 241-244
Murakami, F.; Kiyozuka, Y.; Nishimura, H.; Imamura, K.; Yakushiji, M.; Noda, T.; Adachi, S.; Ito, K.; Tamori, N.; Shintani, M. 1993: Etoposide/cis-platinum (CDDP) combined chemotherapy for ovarian cancer: evaluation of optimum schedule for CDDP administration in chronic continuous exposure of ovarian cancer cells to low-dose etoposide in vitro Nihon Sanka Fujinka Gakkai Zasshi 45(2): 125-132
Rose, P.G.; Hunter, R.E. 1994: Advanced ovarian cancer in a woman with a family history of ovarian cancer, discovered at referral for prophylactic oophorectomy. A case report Journal of Reproductive Medicine 39(11): 908-910
Yazigi, R.; Wild, R.; Madrid, J.; Arraztoa, J. 1984: Ifosfamide treatment of advanced ovarian cancer Obstetrics and Gynecology 63(2): 163-166
Fennelly, D.W.; Aghajanian, C.; Shapiro, F.; O'Flaherty, C.; O'Connor, K.; Curtin, J.P.; Crown, J.P.; Hoskins, W.J.; Spriggs, D.R. 1997: Dose escalation of paclitaxel with high-dose carboplatin using peripheral blood progenitor cell support in patients with advanced ovarian cancer Seminars in Oncology 24(1 Suppl 2: S2
Simm, S.; Wolna, M. 1973: Results of treatment of advanced stage of ovarian cancer Ginekologia Polska 44(1): 45-50
Bruzzone, M.; Campora, E.; Merlini, L.; Giudici, S.; Bottero, G.; Iskra, L.; Donadio, M.; Ferrari, I.; Ragni, N. 1991: Ifosfamide and etoposide salvage treatment in advanced ovarian cancer Journal of ChemoTherapy 3(5): 332-334
Dvorák, O.; Federmann, J.; Honzáková, L. 1982: Medical-economic analysis of the treatment of advanced ovarian cancer Ceskoslovenska Gynekologie 47(10): 755-763
Ozols, R.F. 2000: Paclitaxel (Taxol)/carboplatin combination chemotherapy in the treatment of advanced ovarian cancer Seminars in Oncology 27(3 Suppl 7: 3-7
Markman, M. 1995: Rationale for examining the combination of paclitaxel and ifosfamide in the treatment of advanced ovarian cancer Seminars in Oncology 22(3 Suppl 6: 88-89